See how top analysts and institutions rate OXY — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Wells Fargo | Initiated | Underweight | $42 | 2025-10-17 |
| Mizuho | Upgrade | Neutral → Outperform | $60 | 2025-10-03 |
| HSBC Securities | Upgrade | Hold → Buy | $55 | 2025-10-03 |
| Melius | Initiated | Hold | $64 | 2025-08-20 |
| Morgan Stanley | Downgrade | Overweight → Equal-Weight | $52 | 2025-08-18 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 2 | 5 | 14 | 3 | 0 |
| October 2025 | 2 | 3 | 17 | 2 | 0 |
| September 2025 | 2 | 3 | 17 | 2 | 0 |
| July 2025 | 4 | 3 | 16 | 2 | 0 |
The majority of institutional investors have issued a "Buy" rating for OXY, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
